INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,756,559 | -22.5% | 561,561 | 0.0% | 9.73% | -16.2% |
| Q2 2023 | $22,900,458 | +9.4% | 561,561 | 0.0% | 11.62% | +10.2% |
| Q1 2023 | $20,929,378 | +4.7% | 561,561 | -2.0% | 10.54% | +82.1% |
| Q4 2022 | $19,990,226 | -38.9% | 572,950 | -2.0% | 5.79% | -29.4% |
| Q3 2022 | $32,708,000 | +8.1% | 584,483 | 0.0% | 8.21% | +29.6% |
| Q2 2022 | $30,253,000 | -57.8% | 584,483 | -40.7% | 6.33% | +19.8% |
| Q1 2022 | $71,665,000 | -38.8% | 986,173 | -0.5% | 5.28% | +22.7% |
| Q4 2021 | $117,147,000 | -5.3% | 990,752 | +7.4% | 4.31% | +18.7% |
| Q3 2021 | $123,741,000 | -17.8% | 922,411 | -0.8% | 3.63% | -10.9% |
| Q2 2021 | $150,523,000 | +1180.3% | 929,669 | +534.6% | 4.08% | +958.7% |
| Q1 2021 | $11,757,000 | – | 146,490 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |